Wong Chiew, Chen Sylvia, Iyngkaran Pupalan
Flinders University, NT Medical School, Darwin Australia.
Curr Cardiol Rev. 2017;13(1):63-75. doi: 10.2174/1573403x12666160803100928.
Imaging modalities stand at the frontiers for progress in congestive heart failure (CHF) screening, risk stratification and monitoring. Advancements in echocardiography (ECHO) and Magnetic Resonance Imaging (MRI) have allowed for improved tissue characterizations, cardiac motion analysis, and cardiac performance analysis under stress. Common cardiac comorbidities such as hypertension, metabolic syndromes and chronic renal failure contribute to cardiac remodeling, sharing similar pathophysiological mechanisms starting with interstitial changes, structural changes and finally clinical CHF. These imaging techniques can potentially detect changes earlier. Such information could have clinical benefits for screening, planning preventive therapies and risk stratifying patients. Imaging reports have often focused on traditional measures without factoring these novel parameters. This review is aimed at providing a synopsis on how we can use this information to assess and monitor improvements for CHF with comorbidities.
成像模态处于充血性心力衰竭（CHF）筛查、风险分层和监测进展的前沿。超声心动图（ECHO）和磁共振成像（MRI）的进展使得在应激状态下能够改善组织特征、心脏运动分析和心脏功能分析。常见的心脏合并症，如高血压、代谢综合征和慢性肾衰竭，会导致心脏重塑，它们从间质变化、结构变化到最终临床CHF，都有着相似的病理生理机制。这些成像技术有可能更早地检测到变化。此类信息对于筛查、规划预防性治疗以及对患者进行风险分层可能具有临床益处。成像报告往往侧重于传统指标，而未考虑这些新参数。本综述旨在概述我们如何利用这些信息来评估和监测合并症CHF的改善情况。
